Relationship between Insulin Resistance (HOMA-IR), Trabecular Bone Score (TBS), and Three-Dimensional Dual-Energy X-ray Absorptiometry (3D-DXA) in Non-Diabetic Postmenopausal Women.
3D-DXA
HOMA-IR
HbA1c
TBS
vBMD
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Jun 2020
03 Jun 2020
Historique:
received:
17
04
2020
revised:
16
05
2020
accepted:
29
05
2020
entrez:
7
6
2020
pubmed:
7
6
2020
medline:
7
6
2020
Statut:
epublish
Résumé
Insulin may play a key role in bone metabolism, where the anabolic effect predominates. This study aims to analyze the relationship between insulin resistance and bone quality using the trabecular bone score (TBS) and three-dimensional dual-energy X-ray absorptiometry (3D-DXA) in non-diabetic postmenopausal women by determining cortical and trabecular compartments. A cross-sectional study was conducted in non-diabetic postmenopausal women with suspected or diagnosed osteoporosis. The inclusion criteria were no menstruation for more than 12 months and low bone mass or osteoporosis as defined by DXA. Glucose was calculated using a Hitachi 917 auto-analyzer. Insulin was determined using an enzyme-linked immunosorbent assay (EIA). Insulin resistance was estimated using a homeostasis model assessment of insulin resistance (HOMA-IR). DXA, 3D-DXA, and TBS were thus collected. Moreover, we examined bone parameters according to quartile of insulin, hemoglobin A1C (HbA1c), and HOMA-IR. In this study, we included 381 postmenopausal women. Women located in quartile 4 (Q4) of HOMA-IR had higher values of volumetric bone mineral density (vBMD) but not TBS. The increase was higher in the trabecular compartment (16.4%) than in the cortical compartment (6.4%). Similar results were obtained for insulin. Analysis of the quartiles by HbA1c showed no differences in densitometry values, however women in Q4 had lower levels of TBS. After adjusting for BMI, statistical significance was maintained for TBS, insulin, HOMA-IR, and HbA1c. In non-diabetic postmenopausal women there was a direct relationship between insulin resistance and vBMD, whose effect is directly related to greater weight. TBS had an inverse relationship with HbA1c, insulin, and insulin resistance unrelated to weight. This might be explained by the formation of advanced glycosylation products (AGEs) in the bone matrix, which reduces bone deformation capacity and resistance, as well as increases fragility.
Sections du résumé
BACKGROUND
BACKGROUND
Insulin may play a key role in bone metabolism, where the anabolic effect predominates. This study aims to analyze the relationship between insulin resistance and bone quality using the trabecular bone score (TBS) and three-dimensional dual-energy X-ray absorptiometry (3D-DXA) in non-diabetic postmenopausal women by determining cortical and trabecular compartments.
METHODS
METHODS
A cross-sectional study was conducted in non-diabetic postmenopausal women with suspected or diagnosed osteoporosis. The inclusion criteria were no menstruation for more than 12 months and low bone mass or osteoporosis as defined by DXA. Glucose was calculated using a Hitachi 917 auto-analyzer. Insulin was determined using an enzyme-linked immunosorbent assay (EIA). Insulin resistance was estimated using a homeostasis model assessment of insulin resistance (HOMA-IR). DXA, 3D-DXA, and TBS were thus collected. Moreover, we examined bone parameters according to quartile of insulin, hemoglobin A1C (HbA1c), and HOMA-IR.
RESULTS
RESULTS
In this study, we included 381 postmenopausal women. Women located in quartile 4 (Q4) of HOMA-IR had higher values of volumetric bone mineral density (vBMD) but not TBS. The increase was higher in the trabecular compartment (16.4%) than in the cortical compartment (6.4%). Similar results were obtained for insulin. Analysis of the quartiles by HbA1c showed no differences in densitometry values, however women in Q4 had lower levels of TBS. After adjusting for BMI, statistical significance was maintained for TBS, insulin, HOMA-IR, and HbA1c.
CONCLUSIONS
CONCLUSIONS
In non-diabetic postmenopausal women there was a direct relationship between insulin resistance and vBMD, whose effect is directly related to greater weight. TBS had an inverse relationship with HbA1c, insulin, and insulin resistance unrelated to weight. This might be explained by the formation of advanced glycosylation products (AGEs) in the bone matrix, which reduces bone deformation capacity and resistance, as well as increases fragility.
Identifiants
pubmed: 32503328
pii: jcm9061732
doi: 10.3390/jcm9061732
pmc: PMC7355807
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
J Endocrinol. 2002 Nov;175(2):405-15
pubmed: 12429038
Bone. 2019 Mar;120:232-238
pubmed: 30055341
Osteoporos Int. 2018 Oct;29(10):2323-2333
pubmed: 29974136
Diabetol Metab Syndr. 2017 Oct 19;9:85
pubmed: 29075333
J Clin Endocrinol Metab. 2016 Aug;101(8):3114-22
pubmed: 27243136
IEEE Trans Med Imaging. 2017 Jan;36(1):27-39
pubmed: 27448343
J Clin Endocrinol Metab. 2012 Jan;97(1):234-41
pubmed: 22031520
Cell. 2010 Jul 23;142(2):309-19
pubmed: 20655471
Osteoporos Int. 2005 Nov;16(11):1330-8
pubmed: 15928804
J Clin Densitom. 2015 Jul-Sep;18(3):393-407
pubmed: 26277853
Int J Environ Res Public Health. 2018 Apr 30;15(5):
pubmed: 29710852
J Intern Med. 2018 Feb;283(2):140-153
pubmed: 29265670
Med Image Anal. 2015 Aug;24(1):125-134
pubmed: 26148575
J Bone Metab. 2018 May;25(2):123-132
pubmed: 29900162
Osteoporos Int. 2018 Nov;29(11):2505-2515
pubmed: 30022253
Bone. 2013 Oct;56(2):482-8
pubmed: 23871852
J Bone Metab. 2014 Feb;21(1):41-54
pubmed: 24707466
Metabolism. 1993 Jun;42(6):735-8
pubmed: 8510518
J Clin Densitom. 2018 Nov 13;:
pubmed: 30503030
Calcif Tissue Int. 1996 Dec;59(6):492-5
pubmed: 8939777
Calcif Tissue Int. 2017 Feb;100(2):109-121
pubmed: 27444009
J Bone Miner Res. 1989 Dec;4(6):853-62
pubmed: 2692404
Clin Endocrinol (Oxf). 2019 May;90(5):680-689
pubmed: 30724369
Bone. 2015 Sep;78:216-24
pubmed: 25988660
Bone. 2007 Jul;41(1):19-24
pubmed: 17490921
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3303-3310
pubmed: 30802282
Bone. 2019 Mar;120:85-93
pubmed: 30315999
Arch Intern Med. 2005 Aug 8-22;165(15):1762-8
pubmed: 16087825
J Clin Densitom. 2013 Jan-Mar;16(1):28-32
pubmed: 23374738
HSS J. 2010 Feb;6(1):71-8
pubmed: 19688405
J Clin Densitom. 2015 Jul-Sep;18(3):359-92
pubmed: 26277852
Osteoporos Int. 2016 Jan;27(1):127-33
pubmed: 26187124
Mol Med Rep. 2015 Sep;12(3):3874-3880
pubmed: 25997439
Am J Physiol. 1993 Oct;265(4 Pt 1):E655-9
pubmed: 8238341
Hormones (Athens). 2018 Jun;17(2):205-217
pubmed: 29858847
J Bone Miner Res. 2014 Apr;29(4):796-803
pubmed: 23983216
J Clin Endocrinol Metab. 2013 Feb;98(2):602-9
pubmed: 23341489
Osteoporos Int. 2020 Jun;31(6):1125-1133
pubmed: 32108240